Neurointerventional devices, neurostimulation devices, cranial dopplers, electromyographs, implantable neurostimulators, neurosurgery surgical robots, and skull clamps are some of the most widely used neurology devices.
Statistics:
The global neurology devices market is estimated to account for US$ 44,045.9 Mn in terms of value by the end of 2027.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/3889
Global Neurology Devices Market: Drivers
R&D of new neurology devices is expected to propel growth of the global neurology devices market over the forecast period. For instance, in March 2020, researchers at the Institute for Genomic Medicine at Columbia University Irving Medical Center reported development of enhancement-mode ion-based transistor designed to record the electrical activity of neurons and to perform real-time calculations that help in identifying and monitoring neurological disorders.
Global Neurology Devices Market: Opportunities
Development of novel imaging software for neurological disorders is expected to offer lucrative growth opportunities for players in the global neurology devices market. For instance, in February 2020, Qynapse, a France-based medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration for its QyScore neurodegenerative disease imaging software.
Global Neurology Devices Market: Restraints
Product recalls are expected to hamper the market growth. For instance, in November 2019, The U.S. Food and Drug Administration (FDA) issued a class 1 recall for Zimmer Biomet’s ROSA Brain device, citing a software issue.
Key Takeaways:
The global neurology devices market was valued at US$ 13,572.1 Mn in 2019 and is forecast to reach a value of US$ 44,045.9 Mn by 2027 at a CAGR of 15.9% between 2020 and 2027. Increasing R&D of new neurology devices is expected to propel growth of the global neurology devices market over the forecast period.
Neuro-stimulation Devices segment held dominant position in the global neurology devices market in 2019, accounting for 71.4% share in terms of value, followed by Interventional Neurology Devices and CSF Management devices, respectively. Increasing prevalence of neurological disorders is expected to propel growth of the segment during the forecast period.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3889
Market Trends
Major players in the market are donating neurology devices to aid healthcare systems during Covid-19 pandemic. For instance, in May 2020, BIONIK Laboratories Corp. donated an InMotion robotic system, used to help stroke survivors and those with other neurological conditions regain arm movement, to Einstein Healthcare Network’s MossRehab, an independent medical center in Philadelphia, U.S.
Major players in the market are focused on approval and launch of new devices to expand their product portfolio. For instance, in February 2020, Avanos Medical, Inc. received the U.S. Food and Drug Administration (FDA) approval for its 80-Watt COOLIEF Radiofrequency (RF) system for neurological lesion procedures.
Global Neurology Devices Market: Competitive Landscape
Major players operating in the global neurology devices market include B. Braun Melsungen AG, Boston Scientific Corporation, BIONIK Laboratories Corp., Integra LifeSciences Holdings Corporation, Johnson and Johnson, Magstim Co Ltd., Braintale SAS, Medtronic, plc., Abbott, Zimmer Biomet, Stryker Corporation, Helius Medical Technologies, Inc., Avanos Medical, Inc., W.L. Gore & Associates, Inc., HeadsafeIP Pty Ltd., Cerus Endovascular Ltd., and Cyberonics, Inc.
Global Neurology Devices Market: Key Developments
May 2020: HeadsafeIP Pty Ltd., a privately held brain health technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NUROCHEK system for brain assessment
April 2020: Cerus Endovascular Ltd. received CE Mark approval for its 021 Contour Neurovascular System, compatible with smaller commercially available 021 microcatheters for the treatment of saccular intracranial aneurysms
Read Press Release: https://www.coherentmarketinsights.com/press-release/neurology-devices-market-3157
Segmentation
Scope of the report
- Global Neurology Devices Market, By Device Type:
- CSF Management devices
- CSF Shunt Devices
- CSF Drainage Devices
- Interventional Neurology Devices
- Neuro thromobectomy
- Cerebral Balloon Angioplasty & Stents
- Aneurysm Coiling
- Support Devices
- Neuro-surgery Devices
- Neuro-endoscopes
- Sterotactic- Systems
- Ultrasonic- Aspirators
- Aneurysm Clips
- Neuro-stimulation Devices
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Nerve Stimulation
- CSF Management devices
- Global Neurology Devices Market, By Region:
- North America
- By Device Type:
- CSF Management devices
- CSF Shunt Devices
- CSF Drainage Devices
- Interventional Neurology Devices
- Neuro thromobectomy
- Cerebral Balloon Angioplasty & Stents
- Aneurysm Coiling
- Support Devices
- Neuro-surgery Devices
- Neuro-endoscopes
- Sterotactic- Systems
- Ultrasonic- Aspirators
- Aneurysm Clips
- Neuro-stimulation Devices
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Nerve Stimulation
- CSF Management devices
- By Country
- U.S.
- Canada
- By Device Type:
- Latin America
- By Device Type:
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Device Type:
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Device Type:
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Device Type:
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Device Type:
- By Country
- North Africa
- Central Africa
- South Africa
- North America
- Company Profiles
- B. Braun Melsungen AG *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Boston Scientific Corporation
- BIONIK Laboratories Corp.
- Integra LifeSciences Holdings Corporation
- Johnson and Johnson
- Magstim Co Ltd.
- Braintale SAS
- Medtronic, plc.
- Abbott
- Zimmer Biomet
- Stryker Corporation
- Helius Medical Technologies Inc.
- Avanos Medical, Inc.
- W.L. Gore & Associates, Inc.
- HeadsafeIP Pty Ltd.
- Cerus Endovascular Ltd.
- Cyberonics, Inc.
- B. Braun Melsungen AG *
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837